GlucoTrack (GCTK) News Today $0.25 -0.02 (-7.41%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GlucoTrack Completes Funding to Enhance Financial StabilityNovember 16, 2024 | markets.businessinsider.comGlucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding DebtNovember 14, 2024 | globenewswire.comUnited States shares mixed at close of trade; Dow Jones Industrial Average up 0.11%November 13, 2024 | msn.comGlucotrack, Inc. Announces Pricing of $10.0 Million Public OfferingNovember 13, 2024 | markets.businessinsider.comSay Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is HereOctober 22, 2024 | msn.comGLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCEOctober 22, 2024 | globenewswire.comGlucoTrack (NASDAQ:GCTK) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comGLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETINGOctober 1, 2024 | globenewswire.comJOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORSSeptember 3, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONSAugust 27, 2024 | finance.yahoo.comGlucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual ConferenceAugust 15, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCEAugust 5, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITORJuly 31, 2024 | finance.yahoo.comGLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORSJune 20, 2024 | globenewswire.comGLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSORJune 13, 2024 | globenewswire.comGLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCEJune 10, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITORJune 5, 2024 | globenewswire.comGCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024May 17, 2024 | msn.comGLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDYMay 16, 2024 | finance.yahoo.comGLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDYMay 16, 2024 | globenewswire.comGlucoTrack, Inc.: Glucotrack Announces Reverse Stock SplitMay 16, 2024 | finanznachrichten.deGLUCOTRACK ANNOUNCES REVERSE STOCK SPLITMay 15, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATIONMay 2, 2024 | globenewswire.comGlucoTrack director Drew Sycoff buys $230k in company sharesApril 26, 2024 | investing.comNasdaq Rises 0.5%; Tesla Shares Jump After Q1 ResultsApril 26, 2024 | msn.comGlucoTrack And 2 Other Stocks Under $1 Insiders Are BuyingApril 25, 2024 | msn.comDirector and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK)April 25, 2024 | finance.yahoo.comInsider Buying: GlucoTrack, Inc. (NASDAQ:GCTK) Director Purchases 182,540 Shares of StockApril 25, 2024 | insidertrades.comGLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENTApril 22, 2024 | globenewswire.comGlucoTrack, Inc. (GCTK)April 17, 2024 | finance.yahoo.comGLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORINGApril 16, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITORApril 2, 2024 | globenewswire.comUK mortgage arrears rise 50% amid high interest ratesMarch 13, 2024 | nz.finance.yahoo.comGLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITYMarch 12, 2024 | globenewswire.comGlucoTrack, Inc.: Glucotrack Selects Cirtec Medical As Manufacturer For Its Implantable Continuous Blood Glucose MonitorFebruary 27, 2024 | finanznachrichten.deGLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITORFebruary 27, 2024 | globenewswire.comGlucotrack names Luis Malavé board chairFebruary 13, 2024 | msn.comGLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORSFebruary 13, 2024 | finance.yahoo.comGlucoTrack, Inc.: Glucotrack Announces Early Accuracy Data For Its Implantable Continuous Glucose MonitorJanuary 3, 2024 | finanznachrichten.deGlucoTrack stock jumps 13% on preclinical update for glucose monitorJanuary 2, 2024 | msn.comGLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITORJanuary 2, 2024 | finance.yahoo.comGlucoTrack, Inc.: Glucotrack Announces 180-day Extension To Regain Compliance With Nasdaq Minimum Bid Price RequirementDecember 1, 2023 | finanznachrichten.deNasdaq grants additional 180 days to Glucotrack to regain complianceDecember 1, 2023 | msn.comGLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTNovember 30, 2023 | finance.yahoo.comGLUCOTRACK ANNOUNCES SHAREHOLDER UPDATENovember 13, 2023 | finance.yahoo.comWhy Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day SessionNovember 10, 2023 | msn.comGLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOROctober 12, 2023 | finance.yahoo.comGLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORSAugust 31, 2023 | finance.yahoo.comGLUCOTRACK ANNOUNCES NEW VP OF MARKETINGAugust 28, 2023 | finance.yahoo.comIntegrity Foundation Launches Impactful Nationwide Community Initiative with State-of-the-Art Playground Build in NebraskaAugust 24, 2023 | finance.yahoo.com Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW GCTK Media Mentions By Week GCTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GCTK News Sentiment▼0.150.48▲Average Medical News Sentiment GCTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GCTK Articles This Week▼20▲GCTK Articles Average Week Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AEMD News CTCX News CHEK News POAI News SINT News QNRX News BBLG News NDRA News AVGR News NAOV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GCTK) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GCTK Stock Alerts